The DOI matches its Crossref record.
Consensus report
Open accessAbstract
The International Expert Meeting on Asbestos, Asbestosis, and Cancer was convened in Helsinki on 20--22 January 1997 to discuss disorders of the lung and pleura in association with asbestos and to agree upon state-of-the-art criteria for their diagnosis and attribution with respect to asbestos. The group decided to name this document The Helsinki Criteria . The requirement for diagnostic criteria was perceived in part because of new developments in diagnostic methods, with better identification of asbestos-related disorders. Such developments enhance awareness of health hazards imposed by asbestos, lead to practical prevention and appropriate compensation, and also provide opportunity to carry out international comparisons. They also provide possible models for the risk assessment of other mineral dusts. The meeting was attended by 19 participants from 8 countries not producing asbestos. The chairmen were Professor Douglas W Henderson (Flinders Medical Centre, Australia) and Professor Jorma Rantanen (Finnish Institute of Occupational Health, Finland). The group was a multidisciplinary gathering of pathologists, radiologists, occupational and pulmonary physicians, epidemiologists, toxicologists, industrial hygienists, and clinical and laboratory scientists specializing in tissue fiber analysis. Collectively, the group has published over 1000 articles on asbestos and associated disorders. This document is based on a more comprehensive report providing scientific evidence for the conclusions and recommendations ( People and Work Research Reports , no 14, Finnish Institute of Occupational Health, Helsinki, 1997). The meeting was scientifically supported by leading institutions in the field of asbestos research, and it was funded by the Ministry of Social Affairs and Health and the Finnish Work Environment Fund General considerations Occupational exposures to asbestos dust have been widespread in all industrial countries and continue as a consequence of "in-place" materials. In detailed interviews about 20% to 40% of adult men report some past occupations and jobs that may have entailed asbestos exposure at work. In Western Europe, North America, Japan, and Australia the use of asbestos peaked in the 1970s, and currently about 10 000 mesotheliomas and 20 000 asbestos-induced lung cancers are estimated to occur annually in the population of approximately 800 million people. In general, reliable work histories provide the most practical and useful measure of occupational asbestos exposure. Using structured questionnaires and checklists, trained interviewers can identify persons who have a work history compatible with significant asbestos exposure. Dust measurements can be used in the estimation of past fiber levels at typical workplaces and in the use of asbestos-containing materials. A cumulative fiber dose, as expressed in fiber-years per cubic centimeter, is an important parameter of asbestos exposure. The clinical diagnosis of asbestos-related diseases is based on a detailed interview of the patient and occupational data on asbestos exposure and appropriate latency, signs and symptoms, radiological and lung physiology findings, and selected cytological, histological and other laboratory studies. Histopathological confirmation is required for suspected asbestos-related malignancies and for the resolution of differential diagnoses. A multidisciplinary approach is suggested for the evaluation of problem cases. The chest radiograph is the basic tool for identifying asbestos-related diseases such as asbestosis, pleural abnormalities, lung cancer, and mesothelioma. The limitation of the chest radiograph in the detection of asbestosis and asbestos-associated pleural abnormalities is widely recognized. Computed tomography (CT) and high resolution computed tomography (HRCT) can facilitate the detection of asbestosis and asbestos-related pleural abnormalities, as well as asbestos-related malignancies; they are not recommended as a screening tool but may be invaluable for individual clinical evaluation and research purposes. Examples are the detection of pleural abnormalities in suspected cases of asbestosis and the detection of parenchymal disease obscured on the chest film and also use as an aid to differential diagnosis. As new imaging techniques such as digital radiography are evolving, standard images and interpretations must be developed. The place of other imaging techniques (ultrasound, magnetic resonance imaging, gallium scanning, ventilation-perfusion studies, positron-emission tomography) has yet to be established, and they are not currently recommended for the clinical diagnosis of asbestos-related disorders. Analysis of lung tissue for asbestos fibers and asbestos bodies can provide data to supplement the occupational history. For clinical purposes, the following guidelines are recommended to identify persons with a high probability of exposure to asbestos dust at work: over 0.1 million amphibole fibers (>5
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008
Delgermaa, V., Takahashi, K., Park, E.-K., Le, G. V., Hara, T., & Sorahan, T. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.086678 · Cited by 405
Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos
(2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200310-1436st · Cited by 400
Diseases caused by silica: mechanisms of injury and disease development
Ding, M., Chen, F., Shi, X., Yucesoy, B., Mossman, B., & Vallyathan, V. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00170-9 · Cited by 350
Wolff, H., Vehmas, T., Oksa, P., Rantanen, J., & Vainio, H. (2015) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.3462 · Cited by 289
The Worldwide Pandemic of Asbestos-Related Diseases
Stayner, L., Welch, L. S., & Lemen, R. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031811-124704 · Cited by 262
Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos
Smith, D. D. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.171.6.951 · Cited by 252
Asbestos-induced lung diseases: an update
Kamp, D. W. (2009) · Translational Research · doi:10.1016/j.trsl.2009.01.004 · Cited by 251
Asbestos, Smoking and Lung Cancer: An Update
Klebe, S., Leigh, J., Henderson, D. W., & Nurminen, M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17010258 · Cited by 170
Baumann, F., Buck, B. J., Metcalf, R. V., McLaurin, B. T., Merkler, D. J., & Carbone, M. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000506 · Cited by 128
Mapping the risk of mesothelioma due to neighborhood asbestos exposure
Kurumatani, N., & Kumagai, S. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-063oc · Cited by 126
Mensi, C., Riboldi, L., De Matteis, S., Bertazzi, P. A., & Consonni, D. (2015) · Environment International · doi:10.1016/j.envint.2014.10.016 · Cited by 89
Pascolo, L., Gianoncelli, A., Schneider, G., Salomé, M., Schneider, M., Calligaro, C., Kiskinova, M., Melato, M., & Rizzardi, C. (2013) · Scientific Reports · doi:10.1038/srep01123 · Cited by 88
Exposure to asbestos: past, present and future
Pira, E., Donato, F., Maida, L., & Discalzi, G. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.10.126 · Cited by 68
Dodson, R. F., Hammar, S. P., & Poye, L. W. (2008) · Inhalation Toxicology · doi:10.1080/08958370701883250 · Cited by 39
In-Air Micro-Particle Induced X-ray Emission Analysis of Asbestos and Metals in Lung Tissue
Shimizu, Y., Dobashi, K., Kusakbe, T., Nagamine, T., Oikawa, M., Satoh, T., Haga, J., Ishii, Y., Ohkubo, T., Kamiya, T., et al. (2008) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200802100309 · Cited by 25
Campopiano, A., Cannizzaro, A., Olori, A., Angelosanto, F., Bruno, M. R., Sinopoli, F., Bruni, B. M., Casalinuovo, F., & Iavicoli, S. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140990 · Cited by 13
Metadata
- Authors
- Tossavainen, A.
- Venue
- Scandinavian Journal of Work, Environment & Health
- Published
- 1997-08
- Volume
- 23
- Issue
- 4
- Pages
- 311-316
- ISSN
- 0355-3140 (ISSN-L)
- 1795-990X
- OpenAlex
- W2548076806
- Cited by
- 447
- References
- 0
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.